Navigation Links
Study uses new stem cell therapy in patients up to 19 days after stroke
Date:7/14/2011

HOUSTON (July 14) The first Texas patient has been enrolled by researchers at The University of Texas Health Science Center at Houston (UTHealth) in the country's first double-blind clinical trial studying the safety and efficacy of an innovative stem cell therapy that can be given up to 19 days after an ischemic stroke.

The Phase II study, cleared by the Federal Drug Administration, examines a regenerative therapy developed by Aldagen that uses a patient's own bone marrow stem cells. The therapy, called ALD-401, consists of stem cells that are identified using Aldagen's proprietary technology to isolate cells that express high levels of an enzyme that serve as a marker of stem cells.

Studies found that these cells enhance recovery after stroke in mice. The cells are administered into the carotid artery.

"This represents a new approach using stem cells for stroke," said Sean Savitz, M.D., senior investigator for the multi-center study and associate professor of neurology at the UTHealth Medical School. "A major question in the field of stem cell research is whether we can extend the time window for administering stem cells. A longer window increases the number of patients that might be helped."

Preclinical research, including research at UTHealth, has suggested that stem cells can promote the repair of the brain after an ischemic stroke, which is caused by a blood clot in the brain. Stroke is a leading cause of disability and the fourth-leading cause of death in the United States, according to 2008 statistics reported by the Centers for Disease Control and Prevention.

The Houston resident received either placebo or ALD-401 on June 8 at Memorial Hermann-Texas Medical Center after suffering a stroke May 23 while on a trip to California. Her stroke was caused by previously undiagnosed atrial fibrillation.

"We were waiting for our taxi at the hotel and I immediately couldn't talk and my husband said my f
'/>"/>

Contact: Deborah Lake
deborah.m.lake@uth.tmc.edu
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Study challenges baby formula claim
2. Study explains why men are at higher risk for stomach cancer
3. First study into GM Atlantic salmon mating reveals danger of escape to wild gene pool
4. Your mother was right: Study shows good posture makes you tougher
5. Researchers study pesticide pathways into the atmosphere
6. Scleroderma study identifies roadblocks to employment
7. Study: People at risk for panic buffered from stressor by high levels of physical activity
8. UCI study points to new means of overcoming antiviral resistance in influenza
9. Owl study expands understanding of human stereovision
10. Virginia Tech Coal and Energy Center selected for study of CO2 injection into storage reservoirs
11. Large human study links phthalates, BPA and thyroid hormone levels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study uses new stem cell therapy in patients up to 19 days after stroke
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
(Date:7/8/2015)... 8, 2015 The consumer products industry ... must have products such as wearables, smart wallets & other ... biometrics based devices continues to rapidly grow.  Biometrics & Wearable ... NXTD ), Google Inc. (NASDAQ: GOOG ), Apple Inc. ... GoPro, Inc. (NASDAQ: GPRO ) and Baidu Inc. (NASDAQ: ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) ... Biometrics Market by Application, Technology, Function & Geography - ... The next generation biometrics market is expected ... of 17.9% between 2015 and 2020 Travel ... Safran SA ( France ), ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... with Yale University and the Denver Crime Lab report in ... cancer,s ability to fuse with blood cells in a way ... cancer cells to enter the bloodstream and seed sites of ... a bone marrow transplant patient with cancer, along with DNA ...
... puzzle pieces scattered across a football field, with too ... the picture. Scientists in the new but fast-growing ... In recent decades, these researchers have begun to assemble ... animals, plants and microbes, unlocking a door that will ...
... 2013 Dr. Jeffrey Trent, President and Research Director ... state-of-the-art genomics research July 16 at the Brookings Institution. ... Director of the National Human Genome Research Institute, is ... 2nd annual State of Biomedical Innovation Conference, which will ...
Cached Biology News:CSI-style DNA fingerprinting tracks down cause of cancer spread 2Solving DNA puzzles is overwhelming computer systems, researchers warn 2Solving DNA puzzles is overwhelming computer systems, researchers warn 3TGen President Dr. Jeffrey Trent speaks at Brookings Institution biomedical conference 2
(Date:7/29/2015)... DIEGO , July 29, 2015  Pfenex Inc. ... 2015 financial results will be released on Thursday, August ... am Eastern Time, Pfenex management will host a conference ... business update.  A press release outlining the financial results ... the call. Please call 1-866-376-8058 (US) or ...
(Date:7/29/2015)... ... 2015 , ... The third Medical Innovation Impact Index (MI3) Alert considers FDA ... combinations. The current system received a score of 0 (range -10 to +10) for ... of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and Entrepreneurship. ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... selected an optimized Erk inhibitor molecule for development, ... of a new class of potential cancer therapies. ... prime target for therapeutic intervention in cancer. Recently ... benefits for B-Raf and Mek inhibitors. Erk inhibitors ...
(Date:7/29/2015)... CA. (PRWEB) , ... July 29, 2015 , ... ... with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial ... services, and patient recruitment services. The core expertise of PRC Clinical is focused ...
Breaking Biology Technology:Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3
... Cell,Culture, Life Science Research and Diagnostics Industry Adds Seasoned Sales, ... ... Safety and Time to Market, FORT COLLINS, Colo., ... of animal free,products that enhance productivity, safety and time to ...
... ,UltraShape, the global leader in non-invasive fat reduction and ... President and,Chief Executive Officer., Assaf most recently served ... super-wide format digital printers and,inks, While at NUR, Assaf ... led,to a successful sale to HP. Previously, he served ...
... TorreyPines Therapeutics,Inc. (Nasdaq: TPTX ) today announced ... Market on August 21, 2008., The notice, in ... states that the company,s common stock has,closed below $1.00 ... no immediate effect on the NASDAQ listing or trading ...
Cached Biology Technology:InVitria Expands Sales Team 2InVitria Expands Sales Team 3UltraShape Appoints Assaf Eyal as President & CEO 2UltraShape Appoints Assaf Eyal as President & CEO 3TorreyPines Therapeutics Receives NASDAQ Deficiency Notice 2
CASPR (H-66)...
Mouse monoclonal [PRMT5-21] to PRMT5 ( Abpromise for all tested applications). entrezGeneID: 10419 SwissProtID: O14744...
Mouse Nodal Affinity Purified Polyclonal Ab...
Normal sheep serum collected from healthy normal sheep...
Biology Products: